On May 10, the FDA released two discussion papers on the use of artificial intelligence and machine learning (AI/ML) in drug development and manufacturing. In a statement introducing the papers, Patrizia Cavazzoni, M.D., Director of the FDA Center for Drug Evaluation and Research,…
Source: www.medtechintelligence.com – Read more

Signature Healthcare Brockton Hospital Struck By Cybersecurity Incident – Patch
Signature Healthcare Brockton Hospital Struck By Cybersecurity Incident Patch

